Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12)

Published byJane York Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12)"— Presentation transcript:

1 Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12) and for live birth (OR % CI 0.63–1.08). NC, natural cycle; FET, frozen-thawed embryo transfer. From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2): doi: /humupd/dmw046 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please

2 Figure 3 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET with a subgroup analyses for the use of luteal phase support. OR adjusted for clinical pregnancy in patients not receiving luteal phase support (OR 1.14, 95% CI 0.73–1.77) and patients receiving luteal phase support (OR 0.79, 95% CI 0.60–1.03). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2): doi: /humupd/dmw046 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please

3 Figure 4 Comparison of pregnancy outcomes between NC-FET and artificial cycle FET (AC-FET). OR adjusted for clinical pregnancy (OR 1.18, 95% CI 0.94–1.48). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2): doi: /humupd/dmw046 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please

4 Figure 6 Comparison of pregnancy outcomes between NC-FET and AC-FET with a subgroup analyses for the use of luteal phase support. OR adjusted for clinical pregnancy in patients receiving luteal phase support (OR 1.11, 95% CI 0.88–1.40). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2): doi: /humupd/dmw046 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please

5 Figure 7 Comparison of pregnancy outcomes between NC-FET and AC-FET with GnRH agonist. OR adjusted for clinical pregnancy (OR 0.80, 95% CI 0.66–0.97). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2): doi: /humupd/dmw046 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please

6 Figure 8 Comparison of pregnancy outcomes between AC-FET and AC-FET with GnRH agonist. OR adjusted for clinical pregnancy (OR 0.79, 95% CI 0.43–1.43). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2): doi: /humupd/dmw046 Hum Reprod Update | © The Author Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please

Download ppt "Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12)"

Similar presentations

From: An open day in the metric space

From: An open day in the metric space
Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.
Fig. 1 Flow chart of the COBRA-light trial and its extension study

Fig. 1 Flow chart of the COBRA-light trial and its extension study
From: Global Banking: Recent Developments and Insights from Research*

From: Global Banking: Recent Developments and Insights from Research*
Figure 2. Quality of life (QOL) scores for functional scale items

Figure 2. Quality of life (QOL) scores for functional scale items
Fig. 1 Graphical representation

Fig. 1 Graphical representation
Figure 3. Day 2 cell symmetry

Figure 3. Day 2 cell symmetry
Figure 2. CONSORT flow diagram.

Figure 2. CONSORT flow diagram.
Figure 1 Cumulative chance of pregnancy according to age at initiation of pregnancy seeking. The curves were drawn based on the following assumptions:

Figure 1 Cumulative chance of pregnancy according to age at initiation of pregnancy seeking. The curves were drawn based on the following assumptions:
Figure 1. Mean recalled time (days) since the start of the last quit attempt by use of stop-smoking medications (SSM) and Heaviness of Smoking Index (HSI)

Figure 1. Mean recalled time (days) since the start of the last quit attempt by use of stop-smoking medications (SSM) and Heaviness of Smoking Index (HSI)
Source:Ellerman, Convery, and de Perthuis (2010). Figure 6. 2, p

Source:Ellerman, Convery, and de Perthuis (2010). Figure 6. 2, p
pSS: primary SS; Scl: scleroderma.

pSS: primary SS; Scl: scleroderma.
Figure 1. Selection of papers.

Figure 1. Selection of papers.
Fig. 1 Flow chart of study selection

Fig. 1 Flow chart of study selection
Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.
Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.

Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.
Figure 1 Individual Lifted from Group Photograph

Figure 1 Individual Lifted from Group Photograph
Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser
Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.
Figure 2. Illustration of minimum cross-sectional area (a) and measurements for oropharynx and soft palate in sagittal plane (b, c). From: Airway volume.

Figure 2. Illustration of minimum cross-sectional area (a) and measurements for oropharynx and soft palate in sagittal plane (b, c). From: Airway volume.

Similar presentations

Ads by Google